Tricuspid RegurgitAtion rIsk modeL Study (TRAIL Study)

NCT ID: NCT06926959

Last Updated: 2025-04-15

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

3000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2016-06-15

Study Completion Date

2030-06-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study is a multicenter cohort study including patients diagnosed with tricuspid regurgitation during hospitalization. The primary outcome of the study is all-cause death, and the secondary outcome is cardiovascular events. The prognostic risk factors of patients with tricuspid regurgitation are evaluated, and the prognostic models are constructed through the follow-up observation.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Tricuspid Regurgitation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Aged over 18 yrs.
* Patients diagnosed with tricuspid regurgitation during hospitalization.

Exclusion Criteria

* Patients unable to provide informed consent.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

First Affiliated Hospital, Sun Yat-Sen University

OTHER

Sponsor Role collaborator

Third Affiliated Hospital, Sun Yat-Sen University

OTHER

Sponsor Role collaborator

Affiliated Hospital of Guangdong Medical University

OTHER

Sponsor Role collaborator

Second Affiliated Hospital of Shantou University Medical College

OTHER

Sponsor Role collaborator

Eighth Affiliated Hospital, Sun Yat-sen University

OTHER

Sponsor Role collaborator

Zhongshan People's Hospital, Guangdong, China

OTHER

Sponsor Role collaborator

Jieyang People's Hospital

OTHER

Sponsor Role collaborator

Sun Yat-sen University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Xiao-dong Zhuang

Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

The First Affiliated Hospital of Sun Yat-sen Univerity

Guangzhou, Guangdong, China

Site Status RECRUITING

Third Affiliated Hospital, Sun Yat-Sun University,

Guangzhou, Guangdong, China

Site Status ACTIVE_NOT_RECRUITING

Jieyang People's Hospital

Jieyang, Guangdong, China

Site Status ACTIVE_NOT_RECRUITING

Second Affiliated Hospital of Shantou University Medical College

Shantou, Guangdong, China

Site Status ACTIVE_NOT_RECRUITING

Eighth Affiliated Hospital, Sun Yat-Sen University

Shenzhen, Guangdong, China

Site Status ACTIVE_NOT_RECRUITING

Affiliated Hospital of Guangdong Medical University

Zhanjiang, Guangdong, China

Site Status ACTIVE_NOT_RECRUITING

Zhongshan People's Hospital

Zhongshan, Guangdong, China

Site Status ACTIVE_NOT_RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

China

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Xiaodong Zhuang

Role: CONTACT

+8613760755035

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Xiaodong Zhuang

Role: primary

+8613760755035

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

TRAIL study

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Tricuspid Regurgitation in the ElderlY
NCT05784883 ACTIVE_NOT_RECRUITING